Arrowhead Pharmaceuticals Inc (ARWR)
23.78
-0.14
(-0.59%)
USD |
NASDAQ |
Apr 23, 16:00
23.77
-0.01
(-0.04%)
After-Hours: 20:00
Arrowhead Pharmaceuticals Price to Book Value: 18.36 for April 23, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 22, 2024 | 18.48 |
| April 19, 2024 | 17.25 |
| April 18, 2024 | 17.46 |
| April 17, 2024 | 17.40 |
| April 16, 2024 | 18.28 |
| April 15, 2024 | 18.55 |
| April 12, 2024 | 19.08 |
| April 11, 2024 | 19.84 |
| April 10, 2024 | 19.61 |
| April 09, 2024 | 20.28 |
| April 08, 2024 | 19.85 |
| April 05, 2024 | 19.91 |
| April 04, 2024 | 20.17 |
| April 03, 2024 | 20.45 |
| April 02, 2024 | 20.23 |
| April 01, 2024 | 21.81 |
| March 28, 2024 | 22.09 |
| March 27, 2024 | 22.17 |
| March 26, 2024 | 21.50 |
| March 25, 2024 | 21.54 |
| March 22, 2024 | 21.02 |
| March 21, 2024 | 21.80 |
| March 20, 2024 | 21.75 |
| March 19, 2024 | 21.45 |
| March 18, 2024 | 21.74 |
| Date | Value |
|---|---|
| March 15, 2024 | 21.84 |
| March 14, 2024 | 21.18 |
| March 13, 2024 | 22.08 |
| March 12, 2024 | 22.05 |
| March 11, 2024 | 22.71 |
| March 08, 2024 | 25.84 |
| March 07, 2024 | 25.64 |
| March 06, 2024 | 27.34 |
| March 05, 2024 | 26.32 |
| March 04, 2024 | 27.12 |
| March 01, 2024 | 27.87 |
| February 29, 2024 | 24.79 |
| February 28, 2024 | 26.26 |
| February 27, 2024 | 24.07 |
| February 26, 2024 | 23.55 |
| February 23, 2024 | 24.40 |
| February 22, 2024 | 23.33 |
| February 21, 2024 | 22.54 |
| February 20, 2024 | 22.57 |
| February 16, 2024 | 22.77 |
| February 15, 2024 | 22.84 |
| February 14, 2024 | 22.89 |
| February 13, 2024 | 23.11 |
| February 12, 2024 | 24.92 |
| February 09, 2024 | 25.15 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
4.179
Minimum
Mar 18 2020
30.44
Maximum
Jan 10 2024
12.70
Average
11.10
Median
Nov 17 2023
Price to Book Value Benchmarks
| Madrigal Pharmaceuticals Inc | 10.71 |
| Viking Therapeutics Inc | 18.73 |
| Akero Therapeutics Inc | 2.706 |
| 89bio Inc | 1.584 |
| Sagimet Biosciences Inc | 1.500 |
Price to Book Value Related Metrics
| PS Ratio | 14.05 |
| PEG Ratio | -0.0970 |
| Price | 23.78 |
| Earnings Yield | -11.65% |
| Market Cap | 2.946B |
| PEGY Ratio | -0.0970 |